Company intelligence / Profile preview

Eck Laboratory

Berlin, Berlin, Germany

Ownership: Private
Employees: ~1000
Development stage: Other

Overview

Eckert & Ziegler is a leading global provider of isotope technology for medical, scientific, and industrial use. The company specializes in the development and manufacture of radiopharmaceuticals, radioisotopes, and related medical devices used in nuclear medicine and radiation therapy. Their core business includes the production of Gallium-68 generators and Yttrium-90 for cancer treatment and diagnostics. As a key player in the radiopharmaceutical supply chain, they provide both proprietary products and contract manufacturing services to the global healthcare market.

Therapeutic areas: Oncology
Modalities: RadiopharmaceuticalSmall moleculeIsotope therapy
Industry: Biotech

Partnerships

Telix PharmaceuticalsAriceum Therapeutics

Beyond the preview

Go deeper on Eck Laboratory.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Eck Laboratory.

Explore the full profile